Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use

INTRODUCTION: Lisdexamfetamine dimesylate (LDX) is a long-acting prodrug stimulant for the treatment of attention-deficit/hyperactivity disorder (ADHD). Post hoc subgroup analyses were performed from two studies in children with ADHD to compare the efficacy of LDX in participants who had received pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Rakesh, Babcock, Thomas, Burtea, Teodor, Dirks, Bryan, Adeyi, Ben, Scheckner, Brian, Lasser, Robert, Renna, John, Duncan, Don
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680667/
https://www.ncbi.nlm.nih.gov/pubmed/23681505
http://dx.doi.org/10.1007/s12325-013-0027-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680667/
https://www.ncbi.nlm.nih.gov/pubmed/23681505
http://dx.doi.org/10.1007/s12325-013-0027-2

Ejemplares similares